Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
67.90
-1.81 (-2.60%)
Jan 28, 2026, 3:04 PM CST
109.31%
Market Cap17.99B
Revenue (ttm)1.47B +10.8%
Net Income123.17M -5.5%
EPS0.47 -4.4%
Shares Out264.98M
PE Ratio144.52
Forward PE95.63
Dividendn/a
Ex-Dividend Daten/a
Volume6,536,293
Average Volume7,806,894
Open73.08
Previous Close69.71
Day's Range67.40 - 73.08
52-Week Range26.61 - 90.68
Beta-0.37
RSI37.90
Earnings DateMar 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements